May 18, 2011

Doctors are increasingly seeing people without traditional risk factors for head and neck cancers being diagnosed particularly among younger patients, white males, and non-smokers. This program will provide an overview of the risk factors for head and neck cancer, explain what is the human papillomavirus (HPV) and how it is introduced into the body, who is at risk, treatment options and why HPV induced cancers are treated differently. The prognosis of HPV induced head and neck cancers will be discussed as well as what's on the horizon - including vaccines, deceleration of therapy, and protocols.

Brian Schmidt, DDS, MD, PhD
Professor, Department of Oral and Maxillofacial Surgery

Mark D. DeLacure, MD, FACS
Associate Professor, Departments of Otolaryngology and Surgery (Plastic)

Nicholas J. Sanfilippo, MD
Assistant Professor, Department of Radiation Oncology